Genetic investigation of methylenetetrahydrofolate reductase (MTHFR) and catechol-O-methyl transferase (COMT) in multiple sclerosis

L Tajouri, Jennifer H. Martin, C Gasparini, M Ovcaric, R Curtain, R. A. Lea, LM Haupt, Peter A Csurhes, Michael P. Pender, Lyn R Griffiths

Research output: Contribution to journalArticleResearchpeer-review

16 Citations (Scopus)

Abstract

Multiple sclerosis (MS) is a chronic neurological disease characterized by central nervous system (CNS) inflammation and demyelination. The C677T substitution variant in the methylenetetrahydrofolate reductase (MTHFR) gene has been associated with increased levels of circulating homocysteine and is a mild risk factor for vascular disease. Higher blood levels of homocysteine have also been reported in MS. Thus, the C677T Mutation of the MTHFR gene may influence MS Susceptibility.

Noradrenaline, a neurotransmitter believed to play an immunosupressive role in neuroinflammatory disorders, is catabolized by catechol-O-methyl transferase (COMT). The COMT G158A substitution results in a three- to four-fold decreased activity of the COMT enzyme, which may influence CNS synaptic catecholamine breakdown and could also play a role in MS inflammation.

We tested DNA from Australian MS patients and unaffected control subjects, matched for gender, age and ethnicity. Specifically, we genotyped the MTHFR C677T and the COMT G158A mutations. Genotype distributions showed that the homozygous mutant MTHFR genotype (T/T) and the COMT (H/H) genotype were slightly over-represented in the MS group (16% Versus 11% and 24% versus 19%, respectively), but both variations failed to reach statistical significance (P = 0.15 and P = 0.32, respectively). Hence, results from the present study do not support a major role for either functional gene mutation in MS susceptibility. (c) 2006 Elsevier Inc. All rights reserved.

Original languageEnglish
Pages (from-to)327-331
Number of pages5
JournalBrain Research Bulletin
Volume69
Issue number3
DOIs
Publication statusPublished - 14 Apr 2006
Externally publishedYes

Cite this

Tajouri, L ; Martin, Jennifer H. ; Gasparini, C ; Ovcaric, M ; Curtain, R ; Lea, R. A. ; Haupt, LM ; Csurhes, Peter A ; Pender, Michael P. ; Griffiths, Lyn R. / Genetic investigation of methylenetetrahydrofolate reductase (MTHFR) and catechol-O-methyl transferase (COMT) in multiple sclerosis. In: Brain Research Bulletin. 2006 ; Vol. 69, No. 3. pp. 327-331.
@article{fa5b9435180f4ab78513e90387fd2281,
title = "Genetic investigation of methylenetetrahydrofolate reductase (MTHFR) and catechol-O-methyl transferase (COMT) in multiple sclerosis",
abstract = "Multiple sclerosis (MS) is a chronic neurological disease characterized by central nervous system (CNS) inflammation and demyelination. The C677T substitution variant in the methylenetetrahydrofolate reductase (MTHFR) gene has been associated with increased levels of circulating homocysteine and is a mild risk factor for vascular disease. Higher blood levels of homocysteine have also been reported in MS. Thus, the C677T Mutation of the MTHFR gene may influence MS Susceptibility.Noradrenaline, a neurotransmitter believed to play an immunosupressive role in neuroinflammatory disorders, is catabolized by catechol-O-methyl transferase (COMT). The COMT G158A substitution results in a three- to four-fold decreased activity of the COMT enzyme, which may influence CNS synaptic catecholamine breakdown and could also play a role in MS inflammation.We tested DNA from Australian MS patients and unaffected control subjects, matched for gender, age and ethnicity. Specifically, we genotyped the MTHFR C677T and the COMT G158A mutations. Genotype distributions showed that the homozygous mutant MTHFR genotype (T/T) and the COMT (H/H) genotype were slightly over-represented in the MS group (16{\%} Versus 11{\%} and 24{\%} versus 19{\%}, respectively), but both variations failed to reach statistical significance (P = 0.15 and P = 0.32, respectively). Hence, results from the present study do not support a major role for either functional gene mutation in MS susceptibility. (c) 2006 Elsevier Inc. All rights reserved.",
author = "L Tajouri and Martin, {Jennifer H.} and C Gasparini and M Ovcaric and R Curtain and Lea, {R. A.} and LM Haupt and Csurhes, {Peter A} and Pender, {Michael P.} and Griffiths, {Lyn R}",
year = "2006",
month = "4",
day = "14",
doi = "10.1016/j.brainresbull.2006.01.005",
language = "English",
volume = "69",
pages = "327--331",
journal = "Journal of Electrophysiological Techniques",
issn = "0361-9230",
publisher = "Elsevier",
number = "3",

}

Tajouri, L, Martin, JH, Gasparini, C, Ovcaric, M, Curtain, R, Lea, RA, Haupt, LM, Csurhes, PA, Pender, MP & Griffiths, LR 2006, 'Genetic investigation of methylenetetrahydrofolate reductase (MTHFR) and catechol-O-methyl transferase (COMT) in multiple sclerosis' Brain Research Bulletin, vol. 69, no. 3, pp. 327-331. https://doi.org/10.1016/j.brainresbull.2006.01.005

Genetic investigation of methylenetetrahydrofolate reductase (MTHFR) and catechol-O-methyl transferase (COMT) in multiple sclerosis. / Tajouri, L; Martin, Jennifer H.; Gasparini, C; Ovcaric, M; Curtain, R; Lea, R. A.; Haupt, LM; Csurhes, Peter A; Pender, Michael P.; Griffiths, Lyn R.

In: Brain Research Bulletin, Vol. 69, No. 3, 14.04.2006, p. 327-331.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Genetic investigation of methylenetetrahydrofolate reductase (MTHFR) and catechol-O-methyl transferase (COMT) in multiple sclerosis

AU - Tajouri, L

AU - Martin, Jennifer H.

AU - Gasparini, C

AU - Ovcaric, M

AU - Curtain, R

AU - Lea, R. A.

AU - Haupt, LM

AU - Csurhes, Peter A

AU - Pender, Michael P.

AU - Griffiths, Lyn R

PY - 2006/4/14

Y1 - 2006/4/14

N2 - Multiple sclerosis (MS) is a chronic neurological disease characterized by central nervous system (CNS) inflammation and demyelination. The C677T substitution variant in the methylenetetrahydrofolate reductase (MTHFR) gene has been associated with increased levels of circulating homocysteine and is a mild risk factor for vascular disease. Higher blood levels of homocysteine have also been reported in MS. Thus, the C677T Mutation of the MTHFR gene may influence MS Susceptibility.Noradrenaline, a neurotransmitter believed to play an immunosupressive role in neuroinflammatory disorders, is catabolized by catechol-O-methyl transferase (COMT). The COMT G158A substitution results in a three- to four-fold decreased activity of the COMT enzyme, which may influence CNS synaptic catecholamine breakdown and could also play a role in MS inflammation.We tested DNA from Australian MS patients and unaffected control subjects, matched for gender, age and ethnicity. Specifically, we genotyped the MTHFR C677T and the COMT G158A mutations. Genotype distributions showed that the homozygous mutant MTHFR genotype (T/T) and the COMT (H/H) genotype were slightly over-represented in the MS group (16% Versus 11% and 24% versus 19%, respectively), but both variations failed to reach statistical significance (P = 0.15 and P = 0.32, respectively). Hence, results from the present study do not support a major role for either functional gene mutation in MS susceptibility. (c) 2006 Elsevier Inc. All rights reserved.

AB - Multiple sclerosis (MS) is a chronic neurological disease characterized by central nervous system (CNS) inflammation and demyelination. The C677T substitution variant in the methylenetetrahydrofolate reductase (MTHFR) gene has been associated with increased levels of circulating homocysteine and is a mild risk factor for vascular disease. Higher blood levels of homocysteine have also been reported in MS. Thus, the C677T Mutation of the MTHFR gene may influence MS Susceptibility.Noradrenaline, a neurotransmitter believed to play an immunosupressive role in neuroinflammatory disorders, is catabolized by catechol-O-methyl transferase (COMT). The COMT G158A substitution results in a three- to four-fold decreased activity of the COMT enzyme, which may influence CNS synaptic catecholamine breakdown and could also play a role in MS inflammation.We tested DNA from Australian MS patients and unaffected control subjects, matched for gender, age and ethnicity. Specifically, we genotyped the MTHFR C677T and the COMT G158A mutations. Genotype distributions showed that the homozygous mutant MTHFR genotype (T/T) and the COMT (H/H) genotype were slightly over-represented in the MS group (16% Versus 11% and 24% versus 19%, respectively), but both variations failed to reach statistical significance (P = 0.15 and P = 0.32, respectively). Hence, results from the present study do not support a major role for either functional gene mutation in MS susceptibility. (c) 2006 Elsevier Inc. All rights reserved.

U2 - 10.1016/j.brainresbull.2006.01.005

DO - 10.1016/j.brainresbull.2006.01.005

M3 - Article

VL - 69

SP - 327

EP - 331

JO - Journal of Electrophysiological Techniques

JF - Journal of Electrophysiological Techniques

SN - 0361-9230

IS - 3

ER -